BlueCross BlueShield of Tennessee Medical Policy Manual

Complementary and Alternative Medicine

DESCRIPTION

Complementary and alternative medicine (CAM), as defined by the National Center for Complementary and Alternative Medicine (NCCAM), is a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. Therapies and diagnostics are termed as complementary when used in addition to conventional medicine and as alternative when used instead of conventional medicine.

Integrative Medicine (IM) combines state of the art conventional medicine with alternative modalities to stimulate the body's natural healing potential. IM is based upon a model of health and wellness, as opposed to a model of disease. It seeks to care for the whole person by taking into account the many interrelated physical and nonphysical factors that affect health, wellness, and disease.

Naturopathy is a distinct area of primary care medicine that blends traditional healing methods with current science and research. Naturopathy emphasizes the body’s innate ability to heal itself through the correction of underlying imbalances, and focuses greatly on disease prevention and personal responsibility in the pursuit of optimal health. The predominant research paradigm employed by naturopathy is the whole-system research (WSR) model which evaluates individualized, multifaceted treatment modalities in contrast to randomized clinical trials which attempt to determine the best treatment for large patient populations.

Holistic/naturopathic diagnostics attempt to discover which signs and symptoms of illness are related to human imbalance, or disruption in the homeostasis of the physical, emotional, spiritual, social, and environmental state of the whole being. It is hypothesized that recognition and correction of this imbalance will treat the cause of illness and prevent reoccurrence of symptoms.

In the United States, approximately 38 percent of adults (about 4 in 10) and approximately 12 percent of children (about 1 in 9) are using some form of CAM. Financial analysis reveals that approximately 83 million adults spend $33.9 billion out-of-pocket on CAM which is in excess of 11% of total out-of-pocket health care expenditures.

POLICY

See also:

IMPORTANT REMINDERS

ADDITIONAL INFORMATION

While scientific evidence exists regarding some CAM therapies and diagnostics, for most there are key questions that are yet to be answered through well-designed scientific studies.

Systematic reviews of Traditional Chinese Medicine were inconclusive due specifically to poor methodology and heterogeneity of the studies.

Many CAM products are available on the market as dietary supplements and may be contaminated or vary tremendously resulting in inconsistent dosing. The World Health Organization expresses safety concerns over international marketing of herbal products that may be counterfeit, poor quality or adulterated. Legislation is pending to ensure that the Dietary Supplement Health and Education Act of 1994 is fully implemented with FDA oversight of dietary supplements.

Complementary and alternative medicine including, but not limited to, those listed above, do not meet the following Technology Evaluation Center (TEC) criteria:

SOURCES

111th Congress: 2nd Session: S. 3414: (2010, May). Dietary supplement full implementation and enforcement act of 2010. Retrieved September 7, 2010 from http://thomas.loc.gov .

American Cancer Society. (2000). Complementary and Alternative Cancer Methods. Atlanta: The American Cancer Society.

BlueCross BlueShield Association, Medical Policy Reference Manual. (5:2012). Diagnosis and management of idiopathic environmental intolerances (i.e.multiple chemical sensitivities).  (2.01.01). Retrieved July 2, 2012 from BlueWeb. (18 guidelines and/or articles reviewed)

BlueCross BlueShield Association, Medical Policy Reference Manual. (12:2011). Neural therapy (2.01.85). Retrieved January 11, 2012. (4 guidelines and/or articles reviewed)

Boulton, A., Vinik, A., Arezzo, J., Bril, V., Freeman,R., Malik, R., et al. (2005). Diabetic neuropathies. Diabetic Care 28 (4), 956-962.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Biofeedback therapy (NCD 30.1, p. 2-29). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Biofeedback therapy for the treatment of urinary incontinence (NCD 30.1.1, p. 2-29). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Thermogenic therapy (NCD 30.2, p. 2-30). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Acupuncture – Not covered (NCD 30.3, p. 2-30). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Acupuncture for fibromyalgia (NCD 30.3.1, p. 2-30). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Acupuncture for osteoarthritis (NCD 30.3.2, p. 2-30). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Electrosleep therapy – Not covered (NCD 30.4, p. 2-31). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Transcendental meditation (NCD 30.5, p. 2-31). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Intravenous histamine therapy (NCD 30.6, p. 2-31). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Laetrile and related substances (NCD 30.7, p. 2-32). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Cellular therapy (NCD 30.8, p. 2-32). Ingenix.

Complete Guide to Medicare Coverage Issues [Computer software]. (2010, April). Transillumination light scanning or diaphanography (NCD 30.9, p. 2-32). Ingenix.

Fleming, S., Gutknecht, N. (2010). Naturopathy and the primary care practice. Primary Care, 37(1), 119-136.

Institute of Medicine of the National Academies. (2005). Complementary and Alternative Medicine in the United States. Washington D. C.: The National Academies Press.

Kaul, P. N., & Joshi, B. S. (2001). Alternative medicine: Herbal drugs and their critical appraisal - Part II. Progress in Drug Research, 57, 1-75.

Magill, M. & Suruda, A. (1998). Multiple chemical sensitivity syndrome. American Family Physician, 58 (3), 721-728.

Manheimer, E., Wieland, S., Kimbrough, E., Cheng, K., & Berman, B. (2008) Evidence from the Cochrane collaboration for traditional Chinese medicine therapies. Journal of Alternative and Complementary Medicine, 15 (9), 1001-1014. (Level 1 Evidence - Industry sponsored)

National Cancer Institute. (2008) NCI’s annual report on complementary and alternative medicine. Retrieved September 14, 2010 from http://www.cancer.gov/cam/attachments/fy2008_CAM_annual_report.pdf.

National Institute of Allergy and Infectious Diseases. (2010) Guidelines for the diagnosis and management of food allergy in the United States. Retrieved July 16, 2012 from http://www.niaid.nih.gov/topics/foodAllergy/clinical/Documents/FAGuidelinesExecSummary.pdf.

National Institute of Health, National Center for Complementary and Alternative Medicine (July, 2009). The use of complementary and alternative medicine in the United States. Retrieved September 9, 2010 from: http://nccam.nih.gov/news/camstats/costs/costdatafs.htm.

National Institute of Health, National Center for Complementary and Alternative Medicine (June, 2010). Herbs at a glance. Retrieved September 9, 2010 from: http://nccam.nih.gov/health/NIH_Herbs_at_a_Glance.pdf.

Tennessee Code: Title 63 Professions of the Healing Arts: Chapter 6 Medicine and Surgery: Part 2 General Provisions: 63-6-205. Practice of naturopathy. Retrieved September 7, 2010 from http://www.michie.com/tennessee/lpext.dll?f=templates&fn=main-h.htm&cp=tncode.

Tilburt, J., Curlin, F., Kaptchuk, T., Clarridge, B., Bolcic-Jankovic, D., Emmanuel, E., et al. (2009). Alternative medicine research in clinical practice: a US national survey. Archives of Internal Medicine, 169 (7), 670-677. (Level 5 evidence - Industry sponsored)

Tulppo, M. & Huihuri, H. (2004) Origin and significance of heart rate variability. Journal of the American College of Cardiology, 43 (12) 2278-2279.

U. S. Food and Drug Administration. (2011. April). Center for Devices and Radiological Health. 510(k) Premarket Notification Database. K101867. Retrieved July 3, 2012 from http://www.accessdata.fda.gov/cdrh_docs/pdf10/K101867.pdf.

United States Department of Labor. Occupational Safety and Health Administration. (2011). Multiple chemical sensitivities. Retrieved July 3, 2012 from http://www.osha.gov/SLTC/multiplechemicalsensitivities/index.html.

Voelker, R. (2005). IOM points to need for more research, regulation in alternative medicine. JAMA, 293 (10), 1178-1180.

Winifred S Hayes, Inc. Medical Technology Directory. (2008, August, last update July 2010). Melatonin for jet lag and shift work disorder. Retrieved September 8, 2010 from  https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=8445. (40 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2008, August, last update July 2010). Melatonin for primary sleep disorder. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=8685. (46 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2008, December, last update January 2010). Valerian for the treatment of insomnia. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=9058. (41 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2008, February, last update search February 2010) Horse chestnut for chronic venous insufficiency. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=7731. (19 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2008, January, last update July 2010). St John’s wort for major depressive disorder. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=7586. (31 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2008, September, last update July 2010). Black cohosh for the treatment of menopausal symptoms. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=8605. (34 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2008, September, last update August 2010). Melatonin for secondary sleep disorder. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=8685. (60 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2009, February, last update February 2010). Echinacea for prevention or treatment of the common cold. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=9336. (38 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2009, March, last update March 2010). Craniosacral therapy. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=9514. (22 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2009, March, last update March 2010). Saw palmetto for benign prostatic hyperplasia. Retrieved September 8, 2010 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=9587. (45 articles and/or guidelines reviewed)

Winifred S Hayes, Inc. Medical Technology Directory. (2010, January). Autonomic nervous system monitoring for neuropathy. Retrieved August 8, 2012 from https://www.hayesinc.com/subscribers/subscriberArticlePDF.pdf?articleId=10730 (67 articles and/or guidelines reviewed)

World Health Organization. (2008, December). Traditional medicine. Retrieved September 8, 2010 from http://www.who.int/mediacentre/factsheets/fs134/en/.

ORIGINAL EFFECTIVE DATE: 2/1/2003

MOST RECENT REVIEW DATE:  11/10/2012

ID_BT

Policies included in the Medical Policy Manual are not intended to certify coverage availability. They are medical determinations about a particular technology, service, drug, etc. While a policy or technology may be medically necessary, it could be excluded in a member's benefit plan. Please check with the appropriate claims department to determine if the service in question is a covered service under a particular benefit plan. Use of the Medical Policy Manual is not intended to replace independent medical judgment for treatment of individuals. The content on this Web site is not intended to be a substitute for professional medical advice in any way. Always seek the advice of your physician or other qualified health care provider if you have questions regarding a medical condition or treatment.

This document has been classified as public information.